4.4 Article

In vitro evaluation of new 4-thiazolidinones on invasion and growth of Toxoplasma gondii

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ijpddr.2021.05.004

Keywords

4-Thiazolidinones; Toxoplasma gondii; Cytotoxicity; Invasion; Growth

Funding

  1. Colombian Agency for Science, Technology and Innovation, COLCIENCIAS [57104, 777-2017]
  2. MinCiencias
  3. Ruta N, Colombia
  4. Max Planck Society, Germany
  5. University of Antioquia

Ask authors/readers for more resources

Current treatments for toxoplasmosis have shown side effects, prompting the search for new therapeutic agents. The synthesis of novel 2-hydrazono-4-thiazolidinones derivatives demonstrated potent growth inhibition against T. gondii, suggesting potential anti-parasitic drug properties. The combination of appropriate detection technologies, combinatorial chemistry, and computational biology appears to be an effective strategy for efficient drug discovery.
Treatments for toxoplasmosis such as pyrimethamine have shown numerous side effects. It has been reported that the likelihood of relapse associated with pyrimethamine-based therapy in patients with HIV and toxoplasmic encephalitis (TE) can have significant implications, even for patients who often develop new lesions in areas of the brain previously free of infection. This led us to research for new agents against Toxoplasma gondii. Recent findings have shown the potent biological activity of 4-thiazolidinones. We proposed to design and synthesize a new series of 2-hydrazono-4-thiazolidinones derivatives to evaluate the in vitro growth inhibition effect on T. gondii. The growth rates of T. gondii tachyzoites in Human Foreskin Fibroblast (HFF) cell culture were identified by two in vitro methodologies. The first one was by fluorescence in which green fluorescent RH parasites and cherry-red fluorescent ME49 parasites were used. The second one was a colorimetric methodology using beta-Gal parasites of the RH strain constitutively expressing the enzyme beta-galactosidase. The 4-thiazolidinone derivatives 1B, 2B and 3B showed growth inhibition at the same level of Pyrimethamine. These compounds showed IC50 values of 1B (0.468-0.952 mu M), 2B (0.204-0.349 mu M) and 3B (0.661-1.015 mu M) against T. gondii. As a measure of cytotoxicity the compounds showed a TD50 values of: 1B (60 mu M), 2B (206 mu M) and 3B (125 mu M). The in vitro assays and molecular modeling results suggest that these compounds could act as possible inhibitors of the Calcium-Dependent Protein Kinase 1 of T. gondii. Further, our results support the fact that of combining appropriate detection technologies, combinatorial chemistry and computational biology is a good strategy for efficient drug discovery. These compounds merit in vivo analysis for anti-parasitic drug detection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available